These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15956608)

  • 1. Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation.
    Fukuda M; Longnecker R
    J Virol; 2005 Jul; 79(13):8655-60. PubMed ID: 15956608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
    Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
    Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR.
    Dykstra ML; Longnecker R; Pierce SK
    Immunity; 2001 Jan; 14(1):57-67. PubMed ID: 11163230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
    Miller CL; Lee JH; Kieff E; Burkhardt AL; Bolen JB; Longnecker R
    Infect Agents Dis; 1994; 3(2-3):128-36. PubMed ID: 7812651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
    Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
    J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
    Miller CL; Lee JH; Kieff E; Longnecker R
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
    Swanson-Mungerson M; Bultema R; Longnecker R
    J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
    Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
    J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
    Iwakiri D; Takada K
    J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
    Rovedo M; Longnecker R
    J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
    Fish K; Comoglio F; Shaffer AL; Ji Y; Pan KT; Scheich S; Oellerich A; Doebele C; Ikeda M; Schaller SJ; Nguyen H; Muppidi J; Wright GW; Urlaub H; Serve H; Staudt LM; Longnecker R; Oellerich T
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26318-26327. PubMed ID: 33020271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
    Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
    J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
    Portis T; Longnecker R
    Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.